Will Covidien plc (COV) be Restructuring Soon to Reduce Expenses?
8/5/2013 8:40:17 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Covidien reported its fiscal third-quarter earnings Thursday, which mostly met analyst expectations. The Dublin, Ireland, firm saw revenue climb 3% to $2.58 billion in the quarter ended June 28, from $2.51 billion in the same quarter a year ago. Profits fell to $356 million, or 85 cents per diluted share, down from $453 million, or 81 cents per diluted share in the comparable period in 2012.
Help employers find you! Check out all the jobs and post your resume.
comments powered by